Results 131 to 140 of about 719,508 (214)

ErbB signaling in brain injury regeneration: Pathway interactions and therapeutic potential

open access: yesNeural Regeneration Research
The ErbB signaling network has recently emerged as a key modulator of central nervous system responses to injury. This review provides a comprehensive overview of ErbB receptors and their ligands, highlighting canonical and non-canonical signaling ...
Patricia Pérez-García   +7 more
doaj   +1 more source

Uterine Serous Carcinoma Arising From Endometrial Polyp: A Case Report

open access: yesGynecology Obstetrics & Reproductive Medicine, 2009
Serous carcinoma is the prototype of type II endometrial carcinoma. A 71-year-old woman who had history of smoking, diabetes mellitus and hypertension admitted to the hospital with postmenopausal uterine bleeding.
Sibel Bektaş   +4 more
doaj  

ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner

open access: yes, 1998
The different epidermal growth factor (EGF)-related peptides elicit a diverse array of biological responses as the result of their ability to activate distinct subsets of ErbB receptor dimers, leading to the recruitment of different intracellular ...
Graus-Porta, Diana   +11 more
core   +1 more source

Spinal nerve injury causes upregulation of ErbB2 and ErbB3 receptors in rat dorsal root ganglia

open access: yesJournal of Pain Research, 2013
Satoshi Mizobuchi,1* Hirotaka Kanzaki,1–3* Hiroki Omiya,1 Yoshikazu Matsuoka,1 Norihiko Obata,1 Ryuji Kaku,1 Hirochika Nakajima,1 Mamoru Ouchida,2 Kiyoshi Morita11Department of Anesthesiology and Resuscitology, 2Department of Molecular Genetics,
Mizobuchi S   +8 more
doaj  

Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer

open access: yes, 2008
Udgivelsesdato: 2008-MayErbB receptors (EGFR (ErbB1), ErbB2, ErbB3, and ErbB4) are important regulators of normal growth and differentiation, and they are involved in the pathogenesis of cancer.
Kirstine Roepstorff   +9 more
core   +1 more source

Targeting ErbB Receptors in High-Grade Glioma.

open access: yes, 2011
High-grade gliomas, including glioblastoma, are among the most malignant and treatment-refractory human neoplasms. The tumors show high levels of resistance to conventional therapies (i.e.
Berezowska, S;Schlegel, J
core  

In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer. [PDF]

open access: yesBiol Direct
Lucarini V   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy